Skip to main content
. 2023 Nov 2;8:169. doi: 10.1038/s41541-023-00766-z

Fig. 1. Preparation and characterization of LNP, DiR-LNP, and DiR-LU@LNP.

Fig. 1

a Chemical structures of lipid compositions in LNP carrier of COVID-19 vaccine Comirnaty®. b Schematic illustration of the synthesis of LNP, DiR-LNP, and DiR-LU@LNP. Briefly, the ethanol phase was combined with the aqueous phase at a flow rate ratio of 1:3 (ethanol: aqueous) through a microfluidic mixing device. c Representative cryogenic transmission electron microscopy (Cryo-TEM) images of LNP, DiR-LNP, and DiR-LU@LNP. Scale bar: 50 nm. d Hydrodynamic size (Z-average) and polydispersity index (PDI) of LNP, DiR-LNP, and DiR-LU@LNP measured by DLS. e Zeta potential of LNP, DiR-LNP, and DiR-LU@LNP measured by DLS. Data in (d) and (e) were presented as “mean ± standard deviation” (n = 3). LNP, lipid nanoparticles; DLS, dynamic light scattering; LU-mRNA: luciferase mRNA.